baber/WOPTO huggingface dataset:
Patent DK-0528073-T3 (DK)
Inventor: WILSON VICTOR EDWARD
IPC: E03D9/03
Filed: 1991-05-15
Granted: 1994-10-24
Abstract: A passive dispensing device (10) for use in dosing a toilet bowl (19) with water treatment material comprising: a housing (11) forming a chamber (14) which is adapted to hold water treatment material means (34), reservoir means (12) within the housing (11) for holding a reservoir (25) of water containing said water treatment material (34), water flow path means (17) between the chamber (14) and said reservoir means (25), water flow passageway means (21) extending upwardly away from said reservoir means (12), said passageway means (21) having its lower end (22) in communication with said reservoir means (12) at or adjacent its bottom wall (13), and its open upper end in flow communication with the cistern interior, said upper end being located (Y-Y) below the upper edge of the housing (11) (and below the level of the water within the cistern when full), whereby water, during the filling of the cistern (19) will flow into the reservoir means (12) upwardly along said water flow path means (17) and into the chamber (14), via said passageway means (21), whilst, when the cistern (19) is flushed, a portion only of the water within the device (10) (and containing said water treatment material) will be discharged into the cistern (19) via said passageway means (21). <IMAGE>
Patent DK-0538300-T3 (DK)
Inventor: ADOLF GUENTHER
IPC: C07K14/555
Filed: 1991-07-06
Granted: 1994-10-10
Abstract: The objects of the invention are O-glycosylated IFN-alpha, a process for producing the same and the use of the O-glycosylated proteins as medicinal drugs.
Patent DK-0540588-T3 (DK)
Inventor: SELMER JOHAN
IPC: A61K47/48
Filed: 1991-07-24
Granted: 1995-11-06
Abstract: A pharmaceutical or diagnostic composition comprises, in separate containers, (a) a capturing agent capable of binding to a bioactive substance as well as to a ligand or ligand analogue which is able to bind to a cellular receptor; and (b) a ligand or ligand analogue capable of binding to a cellular receptor as well as to said capturing agent. The composition may be used for providing the rapid clearance of bioactive substances from the circulation.
Patent DK-0542853-T3 (DK)
Inventor: HARDIN SIMON GERARD
IPC: C08L29/04
Filed: 1991-08-08
Granted: 2003-07-14
Abstract: A controlled permeability film including a film forming polymer and optionally including a dispersing polymer; and an inert porous filler optionally having a surface modifying agent coated thereon, the inert porous filler being present in an amount effective to reduce the ratio of the carbon dioxide permeability to the oxigen permeability of the film, and wherein the filler has a particle size greater than the intrinsic film thickness of the film forming polymer. A composite packaging article and a packaged produce product are also disclosed.
Patent DK-0563211-T3 (DK)
Inventor: KLAAR KARLO
IPC: C08K5/098
Filed: 1991-12-13
Granted: 1997-05-20
Abstract: The description relates to a moulding compound for calendering synthetic thermoplastic films or plates and a process for producing films or plates of high-density polyethylene (HDPE) or a mixture of HDPE and ethylene-vinyl acetate copolymer (EVA). The moulding compound consists principally of: a1?) a HDPE or a HDPE mixture; or a2?) a mixture of HDPE and EVA; whereby the moulding compound has: b1?) a melting index MFI (190 C/21.6 kg) to DIN 53 735 of < 7 g/10 min; or b2?) a melting index MFI (190 C/21.6 kg) to DIN 53 735 of < 10 g/10 min and contains 0.5 to 3 % wt. bisstearoyl ethylene diamine and/or metal salts of carboxylic acids as processing auxiliaries. The moulding compound is mixed and plasticised at a temperature of about 170 to 180 C, rolled out to a web at a temperature of 175 to 190 C and finally calendered at a temperature of < 190 C.
Patent DK-0610336-T3 (DK)
Inventor: ROBERTS GARETH
IPC: A61P25/28
Filed: 1992-11-02
Granted: 2002-07-22
Abstract: PCT No. PCT/GB92/02023 Sec. 371 Date Jul. 29, 1994 Sec. 102(e) Date Jul. 29, 1994 PCT Filed Nov. 2, 1992 PCT Pub. No. WO93/08820 PCT Pub. Date May 13, 1993The use of a compound which prevents, inhibits or modifies the action of interleukin-1 as an active agent for the treatment of conditions of neurological degeneration. The active agent may be IL-1 receptor antagonist, particularly recombinant IL-1 ra.
Patent DK-0596512-T3 (DK)
Inventor: WEDI HELMUT
IPC: E04H1/12
Filed: 1993-11-05
Granted: 1998-04-06
Abstract: The invention relates to a rapid-construction partition-wall system for providing flexible partition walls for forming cubicles and partitions in sanitary areas and in wet rooms, comprising   - a metal carrying frame, which exhibits U-legs with rows of perforations (1.1, 1.2, 2; 3.1, ... 3.6; 4.1, ... 4.5), and - filling panels (5.1, ... 5.3; 6), which are fitted together corresponding to the wall height and wall width, the filling-panel edges (13.1, ... 13.6), in the region of the U-legs (1.1, 1.2, 2; 3.1, ... 3.6; 4.1, ... 4.5), being rebated parallel to the edge, and the rebate width corresponding essentially to the width, and the rebate depth corresponding essentially to the thickness, of the U-legs (1.1, 1.2, 2; 3.1, ... 3.6; 4.1, ... 4.5).   The filling panels, configured as corner or surface-covering panels (5.1, ... 5.3; 6), are held, at the outer corners and in corner regions of angle and central-wall regions, by rectilinear U-profiles (1.1, 1.2, 2; 3.1, ... 3.6; 4.1, ... 4.5) provided with rows of perforations and, on the long upper side and underside between the U-profiles (1.1, 1.2, 2; 3.1, ... 3.6; 4.1, ... 4.5), by rectilinear rails (9.1, ... 9.4, 12, 12') with outwardly arranged elevations (10.1, 10.2; 11.1, ... 11.4; 11.1', ... 11.4'). <IMAGE>
Patent DK-0558151-T3 (DK)
Inventor: LYGUM POUL
IPC: A21B1/48
Filed: 1993-02-25
Granted: 1996-03-18
Abstract: An oven has a housing with heating means and a conveyor belt which runs through the housing, and on which the food products to be heated can be conveyed through the housing. The belt follows a first helical path and a second helical path connecting to the first path, in which second path the belt, viewed in the vertical direction, carries out a movement in the opposite direction to that in the first path. <IMAGE>
Patent DK-0564358-T3 (DK)
Inventor: GUILLAUMET GERALD
IPC: C07D491/107
Filed: 1993-04-01
Granted: 1999-07-19
Abstract: The invention relates to the derivatives of general formula (I): <IMAGE>  in which R1, R2, R3, A and m are as defined in the description. Medicaments.
Patent DK-0632693-T3 (DK)
Inventor: LEIFERT CARLO
IPC: A01N63/22
Filed: 1993-03-24
Granted: 1999-09-13
Abstract: PCT No. PCT/GB93/00604 Sec. 371 Date Nov. 1, 1994 Sec. 102(e) Date Nov. 1, 1994 PCT Filed Mar. 24, 1993 PCT Pub. No. WO93/18654 PCT Pub. Date Sep. 30, 1993Isolates of bacteria of species Pseudomonas fluorescens, Serratia liquefaciens, Serratia plymuthica, Bacillus subtilis, Bacillus pumilis and Bacillus polymyxa are effective in cabbages in inhibiting the growth of organisms of the post-harvest disease causing fungi Botrytis cinerea and Alternaria brassicicola.
Patent DK-0610134-T3 (DK)
Inventor: LAUBIE MICHEL
IPC: A61K31/40
Filed: 1994-02-02
Granted: 2000-08-21
Abstract: The invention relates to the compounds of formula (I): <IMAGE>  in which:   R1 represents a hydrogen or halogen atom, an alkyl, alkoxy, cyano or aminocarbonyl group or any one of the following groups: <IMAGE>  -(CH2)m-NH-COR6, -(CH2)m-NH-SO2-R4, <IMAGE>  -(CH2)m-NH-CO-NHR4, <IMAGE>  -(CH2)m-SO2-NH-R4, -CH=CH-SO2-NH-R4, <IMAGE>  in which:     m is equal to 1, 2 or 3,   n is equal to 0, 1 or 2,   T represents a CO or SO2, R4 or R5, which are identical or different, represent a hydrogen atom or an alkyl or phenyl group,     R2 represents a hydrogen atom or an alkyl, phenyl or acyl group, R3 represents a hydrogen atom or an alkyl (optionally substituted by a hydroxyl or phenyl group) or alkoxycarbonyl group,   -X-Y= represents -N-C=, -N-N= or else <IMAGE>  represents -O-N=, to their enantiomers, diastereoisomers and epimers and to their addition salts with a pharmaceutically acceptable acid. Medicaments.
Patent DK-0616237-T3 (DK)
Inventor: ATAR SHAUL
IPC: G02B6/44
Filed: 1994-02-22
Granted: 1997-08-25
Abstract: An optical fiber dispenser (7) for the payout of optical fiber from a moving vehicle so as to maintain a wire communication link with a control station. The dispenser has a bobbin (8) carrying a multi-layer optical fiber pack (9) and holding heating means (11) connectable to a power or heat supply. <IMAGE>
Patent DK-0647623-T3 (DK)
Inventor: BIENAYME HUGUES
IPC: C07B61/00
Filed: 1994-10-05
Granted: 1998-04-14
Abstract: The present invention relates to new intermediates in the preparation of vitamin A and carotenoids corresponding to the following formula (I): <IMAGE> as well as to their process of preparation and to their use.t
Patent DK-0701770-T3 (DK)
Inventor: NEUERBURG HORST
IPC: A01B73/04
Filed: 1995-09-08
Granted: 2002-07-22
Abstract: The locking mechanism (5) equips an agricultural machine which comprises a retractable assembly (1) connected to a fixed structure (2) by a pivot (3). The locking mechanism allows immobilisation of one part of the retractable assembly relative to the fixed structure in one position by a spring steel plate (13) and a stop (17). The retractable assembly is freed by means of an appropriate unlocking tool. In the immobilised position of the retractable assembly, unlocking and retraction necessitates a simultaneous action on the tool and the retractable assembly. Unlocking of the locking mechanism is only possible through a calibrated orifice (19) by means of the tool. The locking mechanism stop is fixed to the retractable assembly or the fixed structure and mates with a complementary part (18), fixed to the structure or retractable assembly, in the locked position.
Patent DK-0729531-T3 (DK)
Inventor: SUHR JOERN
IPC: E01F9/04
Filed: 1994-11-09
Granted: 1999-09-27
Abstract: The invention relates to a fluorescent covering for roads, parking areas etc., which fluoresces upon illumination with ultraviolet light. It comprises organic optical whiteners and pigments, and is characterized in that the binder consists of a solid solution of an amorphous polymer mixture having a glass transition temperature of 20  DEG C to 60  DEG C and a coefficient of elasticity which is less than 1000 MPa at -10  DEG C and greater than 1 MPa at +60  DEG C and which fluoresces upon illumination with ultraviolet light.
Patent DK-0734502-T3 (DK)
Inventor: VERGNE HUBERT
IPC: F21S2/00
Filed: 1994-12-16
Granted: 1999-01-25
Abstract: The object of the invention is an optical fibre of cylindrical construction, providing a lateral light outflow. The optical fibre, which is adapted to convey a light flow from one of its ends, the inlet end (6), to the other end, the outlet end (8), is characterized in that it comprises, at least on a given area (2) of its outer surface, a large number of closely spaced degradations (4) of very small size in relation to the fibre diameter, each of said degradations (4) causing the outflow of conveyed light through the point so that the fibre seems globally illuminated; the surface density of the degradations (4) varies in accordance with the direction of propagation of the light flow, which is thus substantially uniformly discharged over the entire length of the fibre.
Patent DK-0781259-T3 (DK)
Inventor: HAMACHER ALFONS
IPC: C04B35/66
Filed: 1995-09-08
Granted: 1999-01-04
Abstract: The invention concerns the use of a reactive refractory mortar which is self-extinguishing beyond a predetermined penetration depth. The mortar consists of a mixture of 11 to 17 dry wt % aluminium powder, 18 to 31 dry wt % iron oxide, 8 to 18 dry wt % magnesium sulphate dissolved in water and 44 to 60 dry wt % magnesium oxide. The mortar is used for pointing refractory kiln linings consisting of refractory bricks, in particular for rotary kilns.
Patent DK-0722917-T3 (DK)
Inventor: MUELLER PAUL
IPC: C04B28/06
Filed: 1996-01-18
Granted: 1999-12-06
Abstract: Dispersion powder tile adhesive, in powder form, for ceramic tiles contains 7-21 wt.% plastics dispersion powder (I), 7-17 wt.% cement, 0.5-2 wt.% methylcellulose, 1.5-17 wt.% plasticiser, 0.2-2 wt.% setting accelerator and 50-85 wt.% filler, the wt. ratio of (I) to cement being 0.4-3.0.
Patent DK-0730031-T3 (DK)
Inventor: SCHWARTING NORBERT
IPC: C12M1/107
Filed: 1996-01-26
Granted: 1999-11-15
Abstract: The microbial breakdown of substrates loaded with organic matter, esp. waste from large kitchens and bio-waste, is in ≥ 1 stage in a reactor with a first methanisation stage. The organic residue taken from the methanisation stage is sepd., e.g. in a centrifuge in which the residue is conc. and the liq. contained is reduced by 50-85%. The sepn. stage is followed by a second reactor, comprising a second methanisation stage, into which the conc. organic residue from the sepn. is fed.
Patent DK-0824736-T3 (DK)
Inventor: WUNDERER BERND DR
IPC: G07D7/121
Filed: 1996-05-09
Granted: 2000-06-26
Abstract: PCT No. PCT/EP96/01966 Sec. 371 Date Feb. 19, 1998 Sec. 102(e) Date Feb. 19, 1998 PCT Filed May 9, 1996 PCT Pub. No. WO96/36021 PCT Pub. Date Nov. 14, 1996An apparatus for testing sheet material includes an illumination device which illuminates the sheet material continually and in the total spectral region to be tested, and a receiving device having at least two linear parallel CCD arrays. A filter transmitting a certain spectral region is mounted on each CCD array. The individual filters are selected so that at least one transmits in the visible spectral region and one in the invisible spectral region. For detection of the light diffusely reflected or transmitted by the sheet material, the individual CCD arrays produce electric signals from the received light which are then processed in an evaluation device and compared with reference data for testing the sheet material.
Patent DK-0840603-T3 (DK)
Inventor: LEVY RUTH
IPC: A61K9/20
Filed: 1996-07-18
Granted: 2003-01-20
Abstract: The present invention provides a pharmaceutical composition contains a therapeutically effective amount of L-DOPA ethyl ester and a carrier which comprises from 5.5 to 98.5% hydroxypropylmethyl cellulose, from 0.25 to 4.5% hydroxypropyl cellulose, and from 1 to 90% of a carboxyvinyl polymer.
Patent DK-0885240-T3 (DK)
Inventor: FORTE LUIGI
IPC: C07J71/00
Filed: 1996-12-04
Granted: 2001-01-29
Abstract: Process for preparing the compound 11beta-21-dihydroxy-2'-methyl-5'betaH-pregna-1,4-dieno[17,16-d]oxazoline-3,20-dione of formula (I):which comprises adsorbing said compound, contained into an aqueous solution resulting from fermentation broths or process streams, on an adsorbent polymeric resin having a styrenic or acrylic matrix and subsequently desorbing the said compound by eluting the resin with suitable mixture of water with a water-miscible organic solvent.
Patent DK-0790299-T3 (DK)
Inventor: TURNER JAMES EDWARD JR
IPC: C12Q1/18
Filed: 1991-01-24
Granted: 2009-03-02
Abstract: The invention relates to a method for continuously monitoring biological activity in a specimen comprising the steps of providing a device comprising a sealable specimen container with a sealing means, having an internal chamber in which a specimen may be cultured with a culture medium, having a sensor means, wherein changes in the appearance of the sensor means caused by changes in pressure within said sealable container can be continuously monitored from the exterior of said container through a transparent section, thereby monitoring biological activity without violating the integrity of said container after sealing.
Patent DK-0812785-T3 (DK)
Inventor: DECAUX JEAN-FRANCOIS
IPC: B65F1/14
Filed: 1997-06-10
Granted: 2000-02-28
Abstract: A bollard consists of a hollow housing (1) which is fixed to the ground and contains one of more litter bins (4) which are open at the top and have a volume of between 30 and 100 litres. Each bin is located partially underground, with the remainder inside a superstructure (7) set above the ground. The superstructure has holes in the top for depositing litter and one or more opening panels (10) for removing or replacing the bins. The base (5) of the bollard has a cavity (13) which is open at the top to connect with the interior of the superstructure, while each bin has a bottom end (4a) which fits into the cavity below ground level. The base (5) is waterproof and its upper edge (5a) projects some 5cm above the ground. Each opening panel (10) covers an aperture in the wall of the bollard which allows sideways removal and replacement of the bin(s).
Patent DK-0931321-T3 (DK)
Inventor: GRUHN BERND
IPC: H01C1/14
Filed: 1997-09-18
Granted: 2001-02-12
Abstract: PCT No. PCT/DE97/02118 Sec. 371 Date Feb. 23, 1999 Sec. 102(e) Date Feb. 23, 1999 PCT Filed Sep. 18, 1997 PCT Pub. No. WO98/12713 PCT Pub. Date Mar. 26, 1998In a contact assembly for semiconductor resistors, contact elements (5a, 5b) are designed asymmetrically in such a way that, on mutually opposite side faces of an electrical component (3), they bear on it while being mutually offset.
Patent DK-1012162-T3 (DK)
Inventor: PRUSINER STANLEY B
IPC: G01N33/50
Filed: 1997-04-15
Granted: 2003-03-10
Abstract: The invention includes deleting codon segments from DNA expressing a native protein (e.g., PrPSc) in order to obtain a shorter, soluble protein which mimics characteristics of an insoluble native (e.g., PrPSc) protein. Soluble proteins of the invention are characterized by: (1) having less amino acids than the full length native protein; (2) having a higher degree of solubility than the native protein; (3) retaining the basic biological characteristics of the native protein such as (a) not being subject to enzymatic digestion and (b) causing disease. Soluble proteins of the invention are obtained by providing a DNA sequence which encodes a native protein and systematically removing codons, making copies of the shortened versions of DNA which are then expressed to provide the shortened proteins. The shortened proteins are then tested for solubility. Soluble proteins are then further tested to confirm that they retain the biological characteristics of the native protein. The soluble form can also be created by adding amino acids, binding a hydrophilic moiety to the native protein or combinations of deleting, adding, and binding hydrophilic moieties to the protein.
Patent DK-0929486-T3 (DK)
Inventor: BERNARD FREDERIC
IPC: B65G51/03
Filed: 1997-06-04
Granted: 2000-09-25
Abstract: A device for conveying objects having a neck along a given direction having at least one pressure chamber capable of projecting an air flow on the objects along the conveying direction, and a support rail oriented along the conveying direction. The device includes transport shuttles fixed to the neck of the objects and cooperating with the support rail.
Patent DK-0924213-T3 (DK)
Inventor: TAKEMURA MAKOTO
IPC: C07D498/04
Filed: 1997-09-26
Granted: 2006-10-16
Abstract: This invention provides a derivative, and an excellent pharmaceutical preparation, which has strong antibacterial activity against Gram-negative and Gram-positive bacteria and shows both excellent pharmacokinetics and high safety. Particularly, it provides a pyridobenzoxazine derivative represented by formula (I): <CHEM>  wherein   R<1>: a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, in which said alkyl group may have a substituent selected from the group consisting of a hydroxyl group, a halogen atom, an alkylthio group having 1 to 6 carbon atoms and an alkoxyl group having 1 to 6 carbon atoms; R<2>: a hydrogen atom or an amino group, in which said amino group may have one or two substituents selected from the group consisting of a formyl group, an alkyl group having 1 to 6 carbon atoms and an acyl group having 2 to 6 carbon atoms; R<3>: a hydrogen atom, a phenyl group, an acetoxymethyl group, a pivaloyloxymethyl group, an ethoxycarbonyl group, a choline group, a dimethylaminoethyl group, a 5-indanyl group, a phthalidinyl group, a 5-alkyl-2-oxo-1,3-dioxol-4-ylmethyl, a 3-acetoxy-2-oxobutyl group, an alkyl group having 1 to 6 carbon atoms, an alkoxymethyl group having 2 to 7 carbon atoms, a phenylalkyl group composed of an alkylene group having 1 to 6 carbon atoms and a phenyl group; and a salt thereof or a hydrate thereof, or an antibacterial agent containing the same as its active ingredient.
Patent DK-0897015-T3 (DK)
Inventor: SHIMADA KAORU
IPC: C12Q1/26
Filed: 1998-07-27
Granted: 2003-02-24
Abstract: This invention relates to a method for evaluating the susceptibility of pharmaceutical drugs to metabolism by a specific cytochrome P-450 isozyme. which comprises contacting the sample compound with a reagent composition prepared by adding the specific cytochrome P-450 isozyme to liver microsomes lacking said specific cytochrome P-450 isozyme in a carrier material. More particularly, this invention relates to a useful in vitro quantitative assay for drug metabolism by P-450 isozymes such as CYP2D6, CYP2C19, and CYP2A6. This invention also relates to a reagent composition which is useful for said in vitro assay.
Patent DK-1034189-T3 (DK)
Inventor: KOVANEN PETRI
IPC: A61L33/00
Filed: 1998-11-25
Granted: 2008-02-25
Abstract: The present invention is related to heparin-like compounds characterized by their capacity of inhibiting collagen-induced platelet aggregation in flowing whole blood and their use for prophylactic treatment of arterial thrombosis associated with vascular or microvascular injury and interventions. Said properties are related to a high coupling density of negatively charged heparin or heparin-like glycosaminoglycan molecules, present in multiple heparin or heparin-like glycosaminoglycans as well as in proteoglycans containing said multiple heparin or heparin-like glycosaminoglycans or lower-molecular-weight heparin or heparin-like glycosaminoglycans connected directly or through spacer/linker molecules to globular core molecules. Heparin-like compounds, with said properties are obtainable from mammalian mast cells, by tissue extraction or cell cultivation. The heparin-like compounds of the present invention can also be produced by synthetical, semisynthetical and/or biotechnological methods and they are useful for manufacturing preparations, means and devices for local or topical application in prophylactic treatment of arterial thrombosis and its  sequelae.
Patent DK-1069902-T3 (DK)
Inventor: HILLS BRIAN ANDREW
IPC: A61K9/00
Filed: 1998-11-26
Granted: 2004-06-07
Abstract: A medicament is disclosed for reducing the risk of cross-healing ("adhesions") after surgery. The medicament is a dry powder comprising a surface active phospholipid which is capable of binding to mesothical membranes, and a spreading agent. The medicament is applied as a dry powder to the surgical wound site.
Patent DK-1034116-T3 (DK)
Inventor: SUFFA UDO
IPC: B65D55/02
Filed: 1998-10-26
Granted: 2003-07-21
Abstract: A closure cap for closing the opening of a bottle container. A neck of the bottle container includes a latching projection. The closure cap includes a latching arm attached to a ring (R), which circumferentially encircles the neck of the bottle container underneath the latching projection. The ring (R) includes a length store (L) and an undergripping projection. The length store allows the ring (R) to be flexed so that the diameter of the ring is large enough to pass over the latching projection. The undergripping projection is located on the upper side of the ring and sits against the latching projection when the ring (R) is in an unflexed position.
Patent DK-1102824-T3 (DK)
Inventor: MUELLER WOLF-RUEDIGER
IPC: C08L5/00
Filed: 1999-03-23
Granted: 2006-07-24
Abstract: The invention relates to a rub-off, shape-retaining, soft glue stick containing an aqueous preparation composed of starch ethers and saccharose as adhesive components and a soap gel as a modelling skeleton substance, as well as other desired additives. The inventive glue stick is mainly composed of natural starting materials since it can be produced without polyvinylpyrrolidone or additives such as polyetherglycol. The inventive glue stick is characterised by a high bonding capacity, even after being stored for several months in diverse moisture conditions.